MPS1 kinase is an essential component of the spindle assembly checkpoint (SAC), but its functioning mechanisms are not fully understood. We have shown recently that direct interaction between BUBR1 and MAD2 is critical for assembly and function of the human mitotic checkpoint complex (MCC), the SAC effector. Here we report that inhibition of MPS1 kinase activity by reversine disrupts BUBR1-MAD2 as well as CDC20-MAD2 interactions, causing premature activation of the anaphase-promoting complex/cyclosome. The effect of MPS1 inhibition is likely due to reduction of closed MAD2 (C-MAD2), as expressing a MAD2 mutant (MAD2(L13A)) that is locked in the C conformation rescued the checkpoint defects. In the presence of reversine, exogenous C-MAD2 does not localize to unattached kinetochores but is still incorporated into the MCC. Contrary to a previous report, we found that sustained MPS1 activity is required for maintaining both the MAD1·C-MAD2 complex and open MAD2 (O-MAD2) at unattached kinetochores to facilitate C-MAD2 production. Additionally, mitotic phosphorylation of BUBR1 is also affected by MPS1 inhibition but seems dispensable for MCC assembly. Our results support the notion that MPS1 kinase promotes C-MAD2 production and subsequent MCC assembly to activate the SAC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853266PMC
http://dx.doi.org/10.1074/jbc.M113.522375DOI Listing

Publication Analysis

Top Keywords

mps1 kinase
16
kinase promotes
8
closed mad2
8
mad2 c-mad2
8
mitotic checkpoint
8
checkpoint complex
8
mps1 inhibition
8
unattached kinetochores
8
c-mad2 production
8
mcc assembly
8

Similar Publications

MPS1 kinase is a dual specificity kinase that plays an important role in the spindle assembly checkpoint mechanism during cell division. Overexpression of MPS1 kinase is reported in several cancers. However, drug discovery and development efforts targeting MPS1 kinase did not result in any clinically successful candidates.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate the anti-cancer effects of a drug called compound-9, which inhibits a protein known as MPS1/TTK, in gastric cancer cell lines.
  • - Through various assays like cell viability, apoptosis, and protein analysis, the researchers found that sensitivity to the inhibitor varied among different genetic profiles of gastric cancer, particularly noting differences between TP53 mutated and wild-type cell lines.
  • - The findings suggest that compound-9 could be a promising targeted therapy for gastric cancer, especially in cell lines with certain genetic characteristics, by leading to quicker cell death in TP53 wild-type cells compared to mutated ones.
View Article and Find Full Text PDF

Combinatorial Targeting of Common Docking and ATP Binding Sites on Mps1 MAPK for Management of Pathogenic Fungi.

J Agric Food Chem

December 2024

State Key Laboratory of Maize Bio-breeding, Joint International Research Laboratory of Crop Molecular Breeding, China Agricultural University, Beijing 100193, China.

Resistance in pathogenic fungi necessitates the development of fungicides with new mechanisms of action. The Mps1 MAPK of , the pathogen of rice blast disease, has been shown to be a molecular target for fungicide research. Here, we present compound TAK-733 that interacts with the common docking (CD) site of Mps1 and can be used in combination with ATP-competitive inhibitors.

View Article and Find Full Text PDF

Monopolar spindle 1 (Mps1, also known as TTK) and Aurora kinase (AURK) A and B are critical regulators of mitosis and have been linked to the progression of various cancers. Here, we report the design, synthesis, and biological evaluation of a series of PROTACs (proteolysis-targeting chimeras) targeting TTK and AURKs. We synthesized various degrader molecules based on four different 2-aminoadenine-based ligands, recruiting either cereblon or VHL as the E3-ligase.

View Article and Find Full Text PDF
Article Synopsis
  • * A newly designed melatonin derivative with multiflorane substitution has demonstrated strong antifungal activity against multiple plant diseases, outperforming the widely used fungicide azoxystrobin.
  • * The antifungal effects are enhanced by the enantiomer form of the compound, which works by targeting and inhibiting the Mps1 kinase, leading to reduced fungal growth and virulence.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!